Home Overview Press Room Blog Publications For Students about us
Search

About Animal Technologies


Many applications of animal cloning and genetic modification are controversial for environmental, health, animal welfare, and social reasons.

At least eighteen animal species have been cloned since 1996, when scientists produced Dolly the sheep, the world's first cloned mammal. Then and now, only a tiny percentage of cloning attempts produce live offspring. Many of these clones are unhealthy, and some leading scientists believe that none are "normal."

Nonetheless, animal cloning efforts continue. Some are justified as scientific experiments. Others are commercial ventures, either to produce pets for consumers or breeding animals for the livestock industry. The US Food and Drug Administration has approved the inclusion of meat and milk from cloned animals (without labels) in the  food supply.

Like cloning, genetic modification of animals is remarkably inefficient. It is being pursued for several purposes. Genetically modified (or transgenic) animals are commonly used in research. Efforts are underway to produce transgenic pigs as a source of organ transplants, transgenic fish for food, and transgenic livestock that resist animal diseases. In a practice sometimes called pharming, several mammalian species (cattle, sheep, and goats) have been genetically engineered to produce commercially useful human proteins in their milk. Fish engineered to glow in the dark have been developed and marketed as pets. Proposals to clone extinct species, particularly mammoths and neanderthals, regularly appear in the news media.



Review of Blame: A Novelby Abby Lippman, Biopolitical Times guest contributorNovember 28th, 2016Blame is especially important for those unfamiliar with the range of ethical, social, legal, and political issues raised by applications of what is learned in a lab. While a work of fiction, it is definitely not science-fiction
Obama’s Science Advisors Are Worried About Future CRISPR Terrorismby Daniel OberhausVICE MotherboardNovember 21st, 2016PCAST warn that under current legislation, there is no room for rapid response to threats and misuse, recommending improved biosurveillance as a solution.
DNA-editing breakthrough could fix 'broken genes' in the brain, delay ageing and cure incurable diseasesby Ian JohnstonThe Independent [UK]November 16th, 2016The technique allows DNA changes that have not previously been possible, modifying the genes of non-dividing cells in a living animal.
Blood from human teens rejuvenates body and brains of old miceby Jessica HamzelouNew ScientistNovember 15th, 2016A biotech company working with mice is hoping to translate animal research into anti-ageing treatments for humans.
Synthetic human genome project releases its draft timelineby Ike SwelitzStat NewsOctober 28th, 2016HGP-Write rebrands itself suggesting broader visions to synthesize "all sorts of...genomes, not just humans," but issues of transparency loom.
Are Altered Mosquitoes a Public Health Project, or a Business?by Antonio RegaladoMIT Technology ReviewOctober 27th, 2016The fight against dengue and Zika in Latin America is turning into a contest between mosquito-altering technologies, and between profits and public health.
Dangers of an Unscientific Policy Process:
Why the UK’s legalization of “three-person babies” should not be the model for CRISPR
by Jessica Cussins, Biopolitical Times guest contributorOctober 25th, 2016The UK’s consideration of the science and public support for “mitochondrial replacement” may seem robust on its surface, but when it comes to CRISPR germline genome editing policy, we can and must do better.
Mouse eggs made from skin cells in a dishby David CyranoskiNatureOctober 17th, 2016A research breakthrough sparks debate over the prospect of using stem cell techniques to produce synthetic human eggs from body tissue.
CRISPR deployed to combat sickle-cell anaemiaby Heidi LedfordNature NewsOctober 12th, 2016Gene therapy aimed at a single-cell genetic condition shows some success in mice, while highlighting unknowns of human gene editing.
Writing the First Human Genome by 2026 Is Synthetic Biology’s Grand Challengeby Jason DorrierSingularity HubOctober 10th, 2016AutoDesk's Andrew Hessel promises a functional fully synthesized human genome by 2026, continuing the HGP-Write hype that began with a closed meeting at Harvard in May.
Displaying 1-10 of 330  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760